Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, November 20, 2024.
Range Cancer Therapeutics ETF (NASDAQ:CNCR)
Crossroads (-60) - CNCR is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CNCR
The long-term trend has been UP since Sep 13th, 2024 at 15.980
The intermediate-term trend has been DOWN since Nov 14th, 2024 at 14.635
The short-term trend has been DOWN since Nov 14th, 2024 at 14.670
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 13.17 | 13.51 | 13.20 | 13.51 | +0.16 |
| Prev. Close | Volume | Bid | Ask | Time |
| 13.43 | 1716 | 2024-11-19 13:46:10 |
| Year High | 32.32 | Year High Date | 2018-03-13 |
| Year Low | 19.1252 | Year Low Date | 2018-10-29 |
| 52wk High | 17.9599 | 52wk High Date | 2024-03-01 |
| 52wk Low | 10.3 | 52wk Low Date | 2023-11-21 |
| Average Volume | 3,514 | Shares Outstanding | 100 |
| Market Cap | 34M | Volatility | 39.81 |